CD8A and colorectal carcinoma: We evaluated a second CRC cell line and found that TSA-treated HCT116 cells also increased the frequency of CD8+CD25+ cells to 41%, as compared to the frequency activated in the presence of untreated HCT116 cells (36.6%) (Figure 7F).